help button home button Biophys. J.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

Biophys. J. BioFAST: First Published July 13, 2007. doi:10.1529/biophysj.107.112086
© 2007 by the Biophysical Society.


A more recent version of this article appeared on November 1, 2007.
This Article
Right arrow Full Text (Rapid PDF)
Right arrow Supplement
Right arrow All Versions of this Article:
biophysj.107.112086v1
93/9/3015    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Author home page(s):
Patricia Soto
Joan-Emma Shea
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Soto, P.
Right arrow Articles by Shea, J.-E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Soto, P.
Right arrow Articles by Shea, J.-E.

BIOPHYSICAL THEORY AND MODELING

New Insights into the Mechanism of Alzheimer Amyloid-{beta} Fibrillogenesis Inhibition by N-methylated peptides

Patricia Soto 1, Mary A. Griffin 1 and Joan-Emma Shea 1*

1 University of California at Santa Barbara

* To whom correspondence should be addressed. E-mail: shea{at}chem.ucsb.edu.

Submitted on May 3, 2007
Revised on June 5, 2007
Accepted on 27 June 2007


   Abstract
Alzheimer's disease is a debilitating neurodegenerative disorder associated with the abnormal self-assembly of amyloid-{beta} (A{beta}) peptides into fibrillar species. N-methylated peptides homologous to the central hydrophobic core of the A{beta} peptide are potent inhibitors of this aggregation process. In this work, we use fully atomistic molecular dynamics simulations to study the interactions of the N-methylated peptide inhibitor A{beta} 16-20m (Ac-Lys16-(Me)Leu17-Val18-(Me)Phe19-Phe20-NH2) with a model protofilament consisting of Alzheimer A{beta}16-22 peptides. Our simulations indicate that the inhibitor peptide can bind to the protofilament at four different sites: 1) at the edge of the protofilament, 2) on the exposed face of a protofilament layer, 3) between the protofilament layers and 4) between the protofilament strands. The different binding scenarios suggest several mechanisms of fibrillogenesis inhibition: 1) fibril inhibition of longitudinal growth (in the direction of monomer deposition), 2) fibril inhibition of lateral growth (in the direction of protofilament assembly), 3) fibril disassembly by strand removal and perturbation of the periodicity of the protofilament (disruption of fibril morphology). Our simulations suggest that the A{beta}16-20m inhibitor can act on both prefibrillar species and mature fibers and that the specific mechanism of inhibition may depend on the structural nature of the A{beta} aggregate. Disassembly of the fibril can be explained by a mechanism through which the inhibitor peptides bind to disaggregated or otherwise free A{beta}16-22 peptides in solution, leading to a shift in the equilibrium from a fibrillar state to one dominated by inhibitor-bound A{beta}16-22 peptides.

Key Words: Abeta fibrillogenesis, Abeta protofilament, Aggregation inhibition, Molecular dynamics simulation, N-methylated inhibitors




This article has been cited by other articles:


Home page
Biophys. JHome page
A. De Simone, L. Esposito, C. Pedone, and L. Vitagliano
Insights into Stability and Toxicity of Amyloid-Like Oligomers by Replica Exchange Molecular Dynamics Analyses
Biophys. J., August 15, 2008; 95(4): 1965 - 1973.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2007 by the Biophysical Society.